CSF1R and neoplasm: The small molecule CSF1R antagonist named PLX3397 (Pexidartinib), has been found to penetrate the blood-brain barrier and significantly reduce the amount of tumor-associated microglia, thereby preventing tumor invasion in a glioblastoma mouse model 182.